—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Almirall S.A. (ALM.MC) — the peer cohort

As of 2026-10-28 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Almirall S.A. ranks 7 of 7 in its cohort on the Closelooknet composite (53/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 62/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ALM.MC Almirall S.A. 53 30 46 63 info 24.5%
ROVI.MC Laboratorios Farmaceuticos ROVI 62 33 77 50 info 28.1%
BHC.TO Bausch Health Companies Inc 57 81 70 82 info 12.7%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 56 91 58 46 ok 2.4%
GALDY GALDERMA GROUP AG 56 64 59 22 info 4.3%
IRWD Ironwood Pharmaceuticals Inc 56 37 77 83 warn 37.5%
FAGR.BR Fagron NV 54 57 56 58 info 5.7%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-28

Quick answers

Who are Almirall S.A.'s peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Bausch Health Companies Inc (BHC.TO), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), GALDERMA GROUP AG (GALDY), Ironwood Pharmaceuticals Inc (IRWD), Fagron NV (FAGR.BR).

How does ALM.MC score against its peers?

Almirall S.A.'s composite reads 53/100, ranking 7 of 7 in its cohort as of 2026-10-28; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 62/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.